Abstract
Evidence on its benefits and harms is available but is being ignored
MeSH terms
-
Advertising*
-
Drug Industry*
-
Europe
-
Interprofessional Relations
-
Patient Education as Topic
-
Pharmaceutical Preparations / supply & distribution*
-
Private Sector
-
Public Sector
Substances
-
Pharmaceutical Preparations